These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 3948139

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical studies of recombinant interferon alfa-2a (Roferon-A) in cancer patients.
    Taguchi T.
    Cancer; 1986 Apr 15; 57(8 Suppl):1705-8. PubMed ID: 3948142
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. INTRON A (interferon alfa-2b): clinical overview.
    Spiegel RJ.
    Cancer Treat Rev; 1985 Dec 15; 12 Suppl B():5-16. PubMed ID: 3914355
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas.
    Bunn PA, Ihde DC, Foon KA.
    Cancer; 1986 Apr 15; 57(8 Suppl):1689-95. PubMed ID: 3485012
    [Abstract] [Full Text] [Related]

  • 8. Interferons in the treatment of multiple myeloma.
    Cooper MR, Welander CE.
    Cancer; 1987 Feb 01; 59(3 Suppl):594-600. PubMed ID: 3802025
    [Abstract] [Full Text] [Related]

  • 9. Further experience with recombinant interferon alfa-2a with vinblastine in metastatic renal cell carcinoma: a progress report.
    Fosså SD, De Garis ST.
    Int J Cancer Suppl; 1987 Feb 01; 1():36-40. PubMed ID: 3476476
    [Abstract] [Full Text] [Related]

  • 10. The use of interferon in the treatment of multiple myeloma.
    Costanzi JJ, Pollard RB.
    Semin Oncol; 1987 Jun 01; 14(2 Suppl 2):24-8. PubMed ID: 3296211
    [Abstract] [Full Text] [Related]

  • 11. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in hematological malignancies].
    Gan To Kagaku Ryoho; 1985 Apr 01; 12(4):928-35. PubMed ID: 3885864
    [Abstract] [Full Text] [Related]

  • 12. Recombinant interferon alfa-2a in advanced malignant melanoma. A phase I-II study in combination with DTIC.
    McLeod GR, Thomson DB, Hersey P.
    Int J Cancer Suppl; 1987 Apr 01; 1():31-5. PubMed ID: 3476475
    [Abstract] [Full Text] [Related]

  • 13. Phase II study of subcutaneous rHu-interleukin-2 and rHu-interferon alpha-2a in previously treated patients with multiple myeloma.
    Belch AR, Eisenhauer EA, Muldal A, Browman G, Klasa R, Osterwalder B.
    Ann Oncol; 1995 Sep 01; 6(7):721-3. PubMed ID: 8664195
    [Abstract] [Full Text] [Related]

  • 14. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
    Ozer H, Gavigan M, O'Malley J, Thompson D, Dadey B, Nussbaum-Blumenson A, Snider C, Rudnick S, Ferraresi R, Norred S.
    J Biol Response Mod; 1983 Sep 01; 2(6):499-515. PubMed ID: 6607323
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of hematological malignancies with recombinant leukocyte A interferon (rIFN-alpha A)].
    Ohno R, Kodera Y, Ogura M, Murase T, Emi N, Okumura M, Morishita Y, Nagura E, Minami S, Morishima Y.
    Gan To Kagaku Ryoho; 1984 Dec 01; 11(12 Pt 1):2531-6. PubMed ID: 6594973
    [Abstract] [Full Text] [Related]

  • 16. Safety and tolerance of recombinant interferon alfa-2a (Roferon-A) in cancer patients.
    Jones GJ, Itri LM.
    Cancer; 1986 Apr 15; 57(8 Suppl):1709-15. PubMed ID: 3948143
    [Abstract] [Full Text] [Related]

  • 17. Phase II trial of recombinant leukocyte A interferon in advanced malignant melanoma.
    Elsässer-Beile U, Drees N, Neumann HA, Schöpf E.
    J Cancer Res Clin Oncol; 1987 Apr 15; 113(3):273-8. PubMed ID: 3584216
    [Abstract] [Full Text] [Related]

  • 18. Phase II study of recombinant alfa-2a interferon in patients with advanced bone sarcomas.
    Edmonson JH, Long HJ, Frytak S, Smithson WA, Itri LM.
    Cancer Treat Rep; 1987 Apr 15; 71(7-8):747-8. PubMed ID: 3038315
    [Abstract] [Full Text] [Related]

  • 19. Collaborative phase I-II study of recombinant DNA-produced leukocyte interferon (clone A) in metastatic breast cancer, malignant lymphoma, and multiple myeloma.
    Quesada JR, Hawkins M, Horning S, Alexanian R, Borden E, Merigan T, Adams F, Gutterman JU.
    Am J Med; 1984 Sep 15; 77(3):427-32. PubMed ID: 6548079
    [Abstract] [Full Text] [Related]

  • 20. Recombinant interferon alfa-2b (Intron A) as post-induction therapy for responding multiple myeloma patients. M84 protocol.
    Mandelli F, Tribalto M, Avvisati G, Cantonetti M, Petrucci MT, Boccadoro M, Pileri A, Marmont F, Resegotti L, Lauta V.
    Cancer Treat Rev; 1988 Jan 15; 15 Suppl A():43-8. PubMed ID: 3277709
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.